Movicol (Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350)

The macrogol 3350 component is a large polyethylene glycol molecule that is not absorbed. It draws water into the intestinal lumen by osmosis, while the added electrolytes maintain fluid balance. The resulting increase in intestinal water softens the stool and stimulates peristalsis, facilitating evacuation.

The dose of Movicol is individualized. A healthcare professional determines the appropriate amount based on the patient’s age, severity of constipation, and clinical response. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for Movicol in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss use with their healthcare provider.

To order Movicol, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After verification of trade or institutional credentials, the sales team will provide pricing, availability, shipping details and any necessary import documentation.

Compared with stimulant laxatives, Movicol works by osmotic water retention rather than stimulating intestinal muscle activity, resulting in a gentler, more physiologic stool softening. It also contains electrolytes, which helps maintain fluid balance, whereas some other osmotic agents lack this feature.

Movicol powder should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture. Keep the container tightly closed and out of direct sunlight. No refrigeration is required.

The powder is dissolved in a specified volume of water, usually 125 ml, and stirred until fully mixed. The solution is then consumed orally, preferably on an empty stomach or as directed by a healthcare professional.

Serious risks include severe electrolyte imbalance, particularly low sodium or potassium, which can affect heart rhythm and muscle function. Rarely, allergic reactions such as rash, swelling, or breathing difficulty may occur. Prompt medical attention is required if these symptoms develop.

Movicol should be avoided in individuals with known hypersensitivity to any component, in patients with a complete bowel obstruction, or in those with severe renal impairment without medical supervision. It is also contraindicated in patients who require strict fluid restriction.